Long-term tea intake is associated with reduced prevalence of (type 2) diabetes mellitus among elderly people from Mediterranean Islands: MEDIS epidemiological study

Yonsei Medical Journal

Volumn 50, Issue 1, 2009, Pages 31-38

  Panagiotakos, Demosthenes B ^a   Lionis, Christos ^b   Zeimbekis, Akis ^a   Gelastopoulou, Kyriaki ^a   Papairakleous, Natassa ^a   Das, Undurti N ^c   Polychronopoulos, Evangelos ^a  

^a HAROKOPIO UNIVERSITY   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c UND LIFE SCIENCES   (United States)

Author keywords

Cardiovascular risk factors; Diabetes; Elderly; Tea

Indexed keywords

GLUCOSE;

AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; EPIDEMIOLOGICAL DATA; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PREVALENCE; QUESTIONNAIRE; SMOKING; SOUTHERN EUROPE; TEA;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; CYPRUS; DIABETES MELLITUS, TYPE 2; DIET RECORDS; FEMALE; FOOD HABITS; HUMANS; LOGISTIC MODELS; MALE; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; TEA;

EID: 62749188330     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2009.50.1.31     Document Type: Article

References (28)

1. Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea-a review. J Am Coll Nutr 2006;25:79-99.
2. Japanese Green Tea Online.com. [Aaccessed on 30 December 2008]. Available from: URL: http://www.japanesegreenteaonline.com.
3. Weisburger JH. Approaches for chronic disease prevention based on current understanding of underlying mechanisms. Am J Clin Nutr 2000;71 (6 Suppl):1710S-4S; discussion 1715S-9S.
4. Crespy V, Williamson G. A review of the health effects of green tea catechins in in-vivo animal models. J Nutr 2004;134 (12 Suppl):3431S-40S.
5. Sato T, Miyata G. The nutraceutical benefit, part I: green tea. Nutrition 2000;16:315-7.
6. Wiseman S, Mulder T, Rietveld A. Tea flavonoids: bioavailability in vivo and effects on cell signaling pathways in vitro. Antioxid Redox Signal 2001;3:1009-21.
7. Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003;43:89-143.
8. Heber D. Vegetables, fruits and phytoestrogens in the prevention of diseases. J Postgrad Med 2004;50:145-9.
9. Sueoka N, Suganuma M, Sueoka E, Okabe S, Matsuyama S, Imai K, et al. A new function of green tea: prevention of lifestyle-related diseases. Ann N Y Acad Sci 2001;928: 274-80.
10. Zaveri NT. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci 2006;78:2073-80.
11. Koo MW, Cho CH. Pharmacological effects of green tea on the gastrointestinal system. Eur J Pharmacol 2004;500: 177-85.
12. Yang YC, Lu FH, Wu JS, Wu CH, Chang CJ. The protective effect of habitual tea consumption on hypertension. Arch Intern Med 2004;164:1534-40.
13. Fukino Y, Shimbo M, Aoki N, Okubo T, Iso H. Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol (Tokyo) 2005;51:335-42.
14. Tsuneki H, Ishizuka M, Terasawa M, Wu JB, Sasaoka T, Kimura I. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol 2004;4:18.
15. Meydani M. Nutrition interventions in aging and age-associated disease. Ann N Y Acad Sci 2001;928:226-35.
16. Polychronopoulos E, Panagiotakos DB, Polystipioti A. Diet, lifestyle factors and hypercholesterolemia in elderly men and women from Cyprus. Lipids Health Dis 2005;4:17.
17. Panagiotakos DB, Kourlaba G, Zeimbekis A, Toutouzas P, Polychronopoulos E. The J-shape association of alcohol consumption on blood pressure levels, in elderly people from Mediterranean Islands (MEDIS epidemiological study). J Hum Hypertens 2007;21:585-7.
18. Panagiotakos DB, Pitsavos C, Stefanadis C. Dietary patterns: a Mediterranean diet score and its relation to clinical and biological makers of cardiovascular disease risk. Nutr Metab Cardiovasc Dis 2006;16:559-68.
19. Panagiotakos DB, Pitsavos C, Arvaniti F, Stefanadis C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev Med 2007;44:335-40.
20. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35:1381-95.
21. Iso H, Date C, Wakai K, Fukui M, Tamakoshi A; JACC Study Group. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 2006; 144:554-62.
22. Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea - a review. J Am Coll Nutr 2006;25:79-99.
23. Zang M, Xu S, Maitland-Toolan KA, Zuccollo A, Hou X, Jiang B, et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006;55:2180-91.
24. Waltner-Law ME, Wang XL, Law BK, Hall RK, Nawano M, Granner DK. Epigallocatechin gallate, a constituent of green tea, depresses hepatic glucose production. J Biol Chem 2002;277:34933-40.
25. Vlachopoulos C, Alexopoulos N, Dima I, Aznaouridis K, Andreadou I, Stefanadis C. Acute effect of black and green tea on aortic stiffness and wave reflections. J Am Coll Nutr 2006;25:216-23.
26. Janle EM, Portocarrero C, Zhu Y, Zhou Q. Effect of longterm oral administration of green tea extract on weight gain and glucose tolerance in Zucker diabetic (ZDF) rats. J Herb Pharmacother 2005;5:55-65.
27. Stangl V, Lorenz M, Stangl K. The role of tea and tea flavonoids in cardiovascular health. Mol Nutr Food Res 2006;50:218-28.
28. Cheng TO. Is green tea better than black tea in reducing atherosclerosis? Circulation 2004;110:e332.